clavulanic acid has been researched along with Tuberculosis in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 6 (75.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Aubé, J; Ballinger, E; Dartois, V; Gold, B; Hanson, P; Ling, Y; Little, D; Lopez Quezada, L; Mitscher, LA; Nathan, C; Nguyen, Q; Pingle, M; Porubsky, P; Roberts, J; Rogers, S; Schoenen, FJ; Smith, R; Somersan, S; Warrier, T; Zhang, D; Zimmerman, M | 1 |
de Jager, VR; Diacon, AH; Muliaditan, M; van Brakel, E; van der Merwe, L; Vanker, N | 1 |
Raghunand, TR; Viswanathan, G; Yadav, S | 1 |
Blok, AJ; Dai, L; Elings, W; Florea, BI; Kynast, JP; Luu, W; Pannu, NS; Tassoni, R; Timmer, M; Ubbink, M; van der Schoot, SA | 1 |
Sharma, AK; Vats, P | 1 |
Aharonov, R; Bishai, WR; Cohen, KA; Conway, TC; El-Hay, T; Goldschmidt, Y; Munsamy, V; Pym, AS; Shaham, O; Weissbrod, O; Wyres, KL; Yanover, C | 1 |
Holzgrabe, U | 1 |
Jarlier, V; Mainardi, JL; Truffot, C; Veziris, N | 1 |
8 other study(ies) available for clavulanic acid and Tuberculosis
Article | Year |
---|---|
Novel Cephalosporins Selectively Active on Nonreplicating Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Cells, Cultured; Cephalosporins; Female; Hep G2 Cells; Humans; Macrophages; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Microsomes, Liver; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis | 2016 |
Optimizing β-Lactams against Tuberculosis.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Clavulanic Acid; Drug Combinations; Female; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Practice Guidelines as Topic; Tuberculosis; World Health Organization | 2020 |
Identification of Mycobacterial Genes Involved in Antibiotic Sensitivity: Implications for the Treatment of Tuberculosis with β-Lactam-Containing Regimens.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Clavulanic Acid; Dibenzothiepins; Drug Resistance, Microbial; Meropenem; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Thienamycins; Tuberculosis | 2017 |
Phosphate Promotes the Recovery of Mycobacterium tuberculosis β-Lactamase from Clavulanic Acid Inhibition.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Binding Sites; Clavulanic Acid; Drug Resistance, Bacterial; Drug Synergism; Humans; Hydrolysis; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; Phosphates; Tuberculosis | 2017 |
Evaluation of biochemical and molecular polymorphism in extended spectrum β-lactamases of Mycobacterium tuberculosis clinical isolates.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Blotting, Southern; Cefotaxime; Cephalosporins; Clavulanic Acid; Humans; Isoelectric Focusing; Kinetics; Mycobacterium tuberculosis; Polymerase Chain Reaction; Tuberculosis | 2019 |
Paradoxical Hypersusceptibility of Drug-resistant Mycobacteriumtuberculosis to β-lactam Antibiotics.
Topics: Amoxicillin; Anti-Bacterial Agents; Bayes Theorem; beta-Lactamases; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; High-Throughput Nucleotide Sequencing; Humans; Meropenem; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phylogeny; Sequence Analysis, DNA; Thienamycins; Tuberculosis | 2016 |
Meropenem-clavulanate: a new strategy for the treatment of tuberculosis?
Topics: Antitubercular Agents; beta-Lactamase Inhibitors; beta-Lactamases; Clavulanic Acid; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Meropenem; Mycobacterium tuberculosis; Thienamycins; Tuberculosis | 2009 |
Activity of carbapenems combined with clavulanate against murine tuberculosis.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Carbapenems; Clavulanic Acid; Drug Therapy, Combination; Female; Lung; Mice; Microbial Sensitivity Tests; Spleen; Tuberculosis | 2011 |